BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 27103500)

  • 1. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.
    Girmenia C; Bertaina A; Piciocchi A; Perruccio K; Algarotti A; Busca A; Cattaneo C; Raiola AM; Guidi S; Iori AP; Candoni A; Irrera G; Milone G; Marcacci G; Scimè R; Musso M; Cudillo L; Sica S; Castagna L; Corradini P; Marchesi F; Pastore D; Alessandrino EP; Annaloro C; Ciceri F; Santarone S; Nassi L; Farina C; Viscoli C; Rossolini GM; Bonifazi F; Rambaldi A;
    Clin Infect Dis; 2017 Nov; 65(11):1884-1896. PubMed ID: 29020286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
    Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho de Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
    Clin Infect Dis; 2017 Nov; 65(11):1819-1828. PubMed ID: 29020364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
    Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.
    Forcina A; Lorentino F; Marasco V; Oltolini C; Marcatti M; Greco R; Lupo-Stanghellini MT; Carrabba M; Bernardi M; Peccatori J; Corti C; Ciceri F
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1476-1482. PubMed ID: 29501780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
    Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
    Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.
    Hong J; Moon SM; Ahn HK; Sym SJ; Park YS; Park J; Cho YK; Cho EK; Shin DB; Lee JH
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):994-9. PubMed ID: 23571460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
    Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
    Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.
    Harada K; Sekiya N; Konishi T; Nagata A; Yamada Y; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Yasuda S; Sasaki S; Yoshioka K; Watakabe-Inamoto K; Igarashi A; Najima Y; Hagino T; Muto H; Kobayashi T; Doki N; Kakihana K; Sakamaki H; Ohashi K
    BMC Infect Dis; 2017 Sep; 17(1):638. PubMed ID: 28938875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
    Gardner JC; Courter JD; Dandoy CE; Davies SM; Teusink-Cross A
    Transplant Cell Ther; 2022 Mar; 28(3):167.e1-167.e5. PubMed ID: 34875405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study on the usefulness of antibacterial prophylaxis with levofloxacin in patients submitted to hematopoietic stem cell transplantation].
    Fernandez Sojo J; Batlle Massana M; Morgades M; Vives Polo S; Quesada MD; Ribera Santasusana JM
    Med Clin (Barc); 2016 Jan; 146(1):16-9. PubMed ID: 26343154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
    Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes.
    Ford CD; Gazdik MA; Lopansri BK; Webb B; Mitchell B; Coombs J; Hoda D; Petersen FB
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):340-346. PubMed ID: 27890428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
    Satlin MJ; Chavda KD; Baker TM; Chen L; Shashkina E; Soave R; Small CB; Jacobs SE; Shore TB; van Besien K; Westblade LF; Schuetz AN; Fowler VG; Jenkins SG; Walsh TJ; Kreiswirth BN
    Clin Infect Dis; 2018 Nov; 67(11):1720-1728. PubMed ID: 29701766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
    Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.